Attendee Stories

Hear Why Your Peers are Eager to Participate

As an industry first, the Biomarker Operations & Biospecimen Management Summit has been purposely built for the community of directors, heads, VPs and leading stakeholders at pharma and biotech directly responsible for biospecimen and biomarker delivery. Find out exactly why your peers are keen to attend this November.

"The Biospecimen Management Consortium was founded on the belief that the biggest challenges in biospecimen management cannot be solved by any one stakeholder alone. I’m excited to continue that conversation with leaders from across the clinical trial ecosystem and explore how collaboration can help move us forward"

Co-Founder & President, Biospecimen Management Consortium (BMC)

2026 Speaker

"The future of biomarker operations will be defined by our ability to turn data into actionable intelligence. I’m excited to discuss how real-time visibility, automation, and emerging AI capabilities can help organizations move beyond sample tracking towards proactive, data-driven operations that support the next generation of precision medicine"

Senior Manager, Precision Medicine & Clinical Operations Lead, Regeneron

2026 Speaker

"I am excited to participate in this meeting that brings together forward-thinking professionals who are shaping the future of our field. I am looking forward to exchanging ideas, discussing real-world experiences, and exploring how we can collectively make a positive impact"

Director, Biomarker Operations, BioNTech

2026 Speaker

"Proper collection, shipment and storage of clinical samples is critical to the quality of data we get from clinical sample testing. Highlighting the importance of these activities at a dedicated summit is long overdue"

Senior Director, Translational Biomarkers,
Dyne Therapeutics

2026 Speaker

"Biomarker operations sits at the intersection of science, clinical development, and execution, and I hope the shared experiences will allow me to bring back new ideas that can help accelerate the development of innovative therapies for patients"

Senior Director, Translational Operations & Regulatory Integration, Sarepta Therapeutics

2026 Speaker

"Biomarker operations may work behind the scenes, but every breakthrough begins with and relies on getting the right samples"

Head, Oncology Translational Medicine Operations & Experimental Oncology, AstraZeneca

2026 Speaker